- Elevance lifted its 2026 earnings outlook by $2 a share and guided 2027 adjusted earnings to rise at least 12% from a new $26.75 baseline, above the average analyst estimate. Shares rose 1.7% and are up more than 25% this year.
- The composition of that raise deserves attention. Third quarter adjusted profit benefited by $1.85 a share from an increase in the value of private companies Elevance holds stakes in, with the majority from one company chief financial officer Mark Kaye declined to name. That is a valuation gain rather than operating income from insurance.
- The genuinely useful finding concerns consumer behaviour. Individual ACA membership held approximately flat at 1.3 million, which Kaye called surprising, because more enrollees paid their premiums than expected. He said consumers chose affordable bronze plans rather than leaving the market.
- Profitability is also being restored by covering fewer people. Total membership fell to 44.9 million, continuing a multi-year decline, as insurers raise prices, cut benefits and withdraw from less profitable markets. Elevance is winding down Medicaid plans in Washington DC and Louisiana and expects to lose money in that business this year.
What Happened?
Elevance spent less premium revenue on medical care in the quarter than Wall Street anticipated, and attributed the guidance increase to the quarter itself, an improved outlook for its ACA business and the change in value of its private holdings. UnitedHealth raised its own outlook earlier this month. Medicaid faces nearly $1 trillion of funding cuts over the coming decade. Jeff Park, previously president of drug supply chain company Waltz Health, becomes president of Carelon on December 1.
Why It Matters?
The bronze plan finding is the most important thing here and it revises a concern worth revising. The fear as ACA premiums rose roughly 15% was an adverse selection spiral, with healthier members dropping coverage and leaving a sicker, costlier pool behind. Elevance’s experience suggests something different: people are not leaving, they are trading down to the cheapest tier available. For insurers that is a considerably better outcome, since the pool stays intact. For households it is worse, because bronze plans carry the highest deductibles and the greatest out-of-pocket exposure. The result is people who remain nominally insured while facing far more cost before coverage begins, which is consistent with roughly 30% of insured adults reporting they have skipped or delayed care. The earnings composition matters for anyone taking the guidance at face value. A $2 raise of which $1.85 a share derives from revaluing private holdings, mostly one undisclosed company, is not the same as a $2 improvement in underwriting. Those marks can move in either direction and tell you nothing about medical cost trends. The underlying operating news is real but narrower: medical spending came in below expectations and the ACA book held up. The membership decline is the honest counterpart to the margin recovery. Insurers have restored profitability partly by insuring fewer people, withdrawing from unprofitable markets and exiting Medicaid programmes facing substantial federal cuts. That is rational corporate behaviour and it means the improvement in results and the deterioration in household healthcare affordability are describing the same adjustment from opposite ends.
What Next?
Open enrolment will show whether the trade-down to bronze plans continues or whether members eventually exit, which determines if the pool remains stable. Watch the medical loss ratio in coming quarters as the cleaner measure of underwriting than headline earnings. Medicaid cuts of nearly $1 trillion over a decade are the structural pressure, and further programme exits are likely. For the sector, whether Centene and other ACA-heavy insurers report the same bronze plan migration would confirm it as a market-wide behaviour rather than one company’s experience.
Affected Tickers and Coins: ELV, UNH, CNC
Source: Bloomberg
